MTOR and hepatocellular carcinoma: [89] demonstrated that PRMT4 is overexpressed in HCC tumour tissues and facilitates the progression of hepatocellular carcinoma by activating the AKT/mTOR signalling pathway, also suggesting a poor prognosis.